Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

CORT Corcept Therapeutics

Watchlist
24.320
-0.150-0.61%
Close  02/03 16:00 ET
24.3200.0000.00%
Post Mkt Price 02/03 16:04 ET
High
24.870
Open
24.370
Turnover
14.89M
Low
23.930
Pre Close
24.470
Volume
611.79K
Market Cap
2.62B
P/E(TTM)
24.57
52wk High
30.140
Shares
107.65M
P/E(Static)
27.33
52wk Low
17.190
Float Cap
2.13B
Bid/Ask %
0.00%
Historical High
31.180
Shs Float
87.49M
Volume Ratio
1.01
Historical Low
0.680
Dividend TTM
--
Div Yield TTM
--
P/B
5.53
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.70%
Amplitude
3.84%
Avg Price
24.344
Lot Size
1
Float Cap
2.13B
Bid/Ask %
0.00%
Historical High
31.180
Shs Float
87.49M
Volume Ratio
1.01
Historical Low
0.680
Dividend TTM
--
P/B
5.53
Dividend LFY
--
Turnover Ratio
0.70%
Amplitude
3.84%
Avg Price
24.344
Lot Size
1
Price Forecast

News

Comment

Company Overview More
Corcept Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the discovery, development and commercialization of medications to treat severe metabolic, oncologic and psychiatric disorders. It focuses on the development of drugs for disorders that are associated with a steroid hormone called cortisol. Its products include korlym and korlym support. The company was founded by David B. Singer and Joseph K. Belanoff on May 13, 1998 and is headquartered in Menlo Park, CA.
CEO: Dr. Joseph K. Belanoff, M.D.
Market: NASDAQ
Listing Date: 04/14/2004
Paper Trade More
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist